MRIdian LINAC
Device
VIEWRAY TECHNOLOGIES INC
Total Payments
$1.8M
Transactions
577
Doctors
157
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $1.8M | 577 | 157 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.5M | 78 | 81.4% |
| Consulting Fee | $187,534 | 74 | 10.3% |
| Travel and Lodging | $55,039 | 88 | 3.0% |
| Education | $40,290 | 4 | 2.2% |
| Food and Beverage | $32,901 | 327 | 1.8% |
| Honoraria | $21,900 | 5 | 1.2% |
| Gift | $189.41 | 1 | 0.0% |
Payments by Type
Research
$1.5M
78 transactions
General
$337,853
499 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| MIRAGE, HEATWAVE, & EXCALIBUR | VIEWRAY TECHNOLOGIES INC | $250,725 | 0 |
| Prospective Phase II Study of Stereotactic MR-guided ontable Adaptive Radiation Therapy for Patients with Borderline or Inoperable Locally Advanced Pancreatic (SMART Study) | VIEWRAY TECHNOLOGIES INC | $243,199 | 0 |
| Northwestern IIS (multiple projects funded) | VIEWRAY TECHNOLOGIES INC | $175,000 | 0 |
| FORT Prostate Reasearch Study | VIEWRAY TECHNOLOGIES INC | $119,687 | 0 |
| Phase II Study of LUNG STereotactic Adaptive Ablative Radiotherapy for Central and Ultracentral Tumors. (LUNG STAAR) | VIEWRAY TECHNOLOGIES INC | $100,000 | 0 |
| A Feasibility Study of Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction for Inoperable Primary or Metastatic Carcinoma (SMART ONE) | VIEWRAY TECHNOLOGIES INC | $90,000 | 0 |
| Preoperative MR-Guided Radiation Therapy to Improve Oncologic Outcomes in Gastric Cancer | VIEWRAY TECHNOLOGIES INC | $75,000 | 0 |
| Enhancing the efficacy of PDAC directed SBRT by prevention of ADAM10 driven cytotoxic resistance and metastasis | VIEWRAY TECHNOLOGIES INC | $68,000 | 0 |
| H/N Research Project | VIEWRAY TECHNOLOGIES INC | $65,340 | 0 |
| SHORTER Study | VIEWRAY TECHNOLOGIES INC | $60,533 | 0 |
| Prospective Study of Stereotactic Body Radio Therapy (SBRT) Following Radical Prostatectomy | VIEWRAY TECHNOLOGIES INC | $56,549 | 0 |
| Nanobody Immune-guided Radiation Therapy | VIEWRAY TECHNOLOGIES INC | $30,000 | 0 |
| MRI Guided Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma to Enhance Complete Response | VIEWRAY TECHNOLOGIES INC | $29,791 | 0 |
| High Precision Cardiac Motion Modeling and Gating Using the MRIdian System Healthy Volunteer Study | VIEWRAY TECHNOLOGIES INC | $15,592 | 0 |
| Feasibility and efficacy of neoadjuvant MR-guided radiotherapy with concurrent carboplatin/paclitaxel in locally advanced gastric cancer) | VIEWRAY TECHNOLOGIES INC | $14,531 | 0 |
| MRI Guided Cavity Radiation in Resected Brain Metastasis | VIEWRAY TECHNOLOGIES INC | $14,419 | 0 |
| Feasibility of ViewRay MRIdian MRI-LINAC for spine stereotactic body radiation therapy (SBRT) | VIEWRAY TECHNOLOGIES INC | $12,480 | 0 |
| RSSearch Radiation Registry | VIEWRAY TECHNOLOGIES INC | $10,000 | 0 |
| Phase 2 Clinical Trial of Radiomic Habitat-Directed Radiation Dose Escalation for High-Grade Soft Tissue Sarcoma | VIEWRAY TECHNOLOGIES INC | $8,995 | 0 |
| PF-ROAR | VIEWRAY TECHNOLOGIES INC | $8,250 | 0 |
Top Doctors Receiving Payments for MRIdian LINAC
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boca Raton, FL | $1.5M | 86 |
| , MD | Radiation Oncology | Miami, FL | $61,407 | 30 |
| , MD | Radiation Oncology | Los Angeles, CA | $38,419 | 27 |
| Jessica Frakes | Radiation Oncology | Tampa, FL | $22,125 | 14 |
| , M.D | Radiation Oncology | Los Angeles, CA | $21,622 | 18 |
| , MD | Radiation Oncology | Los Angeles, CA | $18,589 | 6 |
| , MD | Radiation Oncology | Detroit, MI | $11,881 | 26 |
| , M.D | Radiation Oncology | Columbus, OH | $10,648 | 3 |
| , M.D | Radiation Oncology | Miami, FL | $10,481 | 15 |
| , M.D | Radiation Oncology | Los Angeles, CA | $7,682 | 8 |
| , M.D | Radiation Oncology | Miami, FL | $6,800 | 3 |
| Jonathan Clark | Radiation Oncology | Chico, CA | $6,411 | 7 |
| , MD, PHD | Internal Medicine | Boston, MA | $5,891 | 6 |
| , MD, PHD | Radiation Oncology | Chicago, IL | $5,215 | 9 |
| , D.O | Radiation Oncology | Voorhees, NJ | $4,060 | 1 |
| , M.D | Radiation Oncology | Newark, DE | $4,051 | 6 |
| , M.D | Radiation Oncology | Boston, MA | $4,026 | 7 |
| Stephen Rosenberg | Radiation Oncology | Madison, WI | $3,904 | 9 |
| , MD | Radiation Oncology | Saint Louis, MO | $3,871 | 3 |
| , MD | Hematology & Oncology | Miami, FL | $2,400 | 3 |
| , M.D., PH.D | Radiation Oncology | Miami, FL | $2,235 | 7 |
| , MD, PHD | Radiation Oncology | Portland, OR | $2,173 | 16 |
| , MD | Radiation Oncology | Albany, NY | $2,086 | 10 |
| , M.D | Radiation Oncology | Portland, OR | $1,814 | 9 |
| , M.D | Radiation Oncology | Boston, MA | $1,574 | 4 |
Ad
Manufacturing Companies
- VIEWRAY TECHNOLOGIES INC $1.8M
Product Information
- Type Device
- Total Payments $1.8M
- Total Doctors 157
- Transactions 577
About MRIdian LINAC
MRIdian LINAC is a device associated with $1.8M in payments to 157 healthcare providers, recorded across 577 transactions in the CMS Open Payments database. The primary manufacturer is VIEWRAY TECHNOLOGIES INC.
Payment data is available from 2022 to 2022. In 2022, $1.8M was paid across 577 transactions to 157 doctors.
The most common payment nature for MRIdian LINAC is "Unspecified" ($1.5M, 81.4% of total).
MRIdian LINAC is associated with 20 research studies, including "MIRAGE, HEATWAVE, & EXCALIBUR" ($250,725).